[go: up one dir, main page]

AR122491A1 - Agente preventivo de adhesión y método preventivo de adhesión usando el mismo - Google Patents

Agente preventivo de adhesión y método preventivo de adhesión usando el mismo

Info

Publication number
AR122491A1
AR122491A1 ARP210101482A ARP210101482A AR122491A1 AR 122491 A1 AR122491 A1 AR 122491A1 AR P210101482 A ARP210101482 A AR P210101482A AR P210101482 A ARP210101482 A AR P210101482A AR 122491 A1 AR122491 A1 AR 122491A1
Authority
AR
Argentina
Prior art keywords
adhesion preventive
same
agent
adhesion prevention
adhesion
Prior art date
Application number
ARP210101482A
Other languages
English (en)
Inventor
Atsushi OHHATA
Hiromichi Yamashita
Shiori Fujimoto
Original Assignee
Otsuka Pharma Factory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Factory Inc filed Critical Otsuka Pharma Factory Inc
Publication of AR122491A1 publication Critical patent/AR122491A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Sealing Material Composition (AREA)
  • Paints Or Removers (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Adhesives Or Adhesive Processes (AREA)

Abstract

Se proporcionan un agente de prevención de adherencia y un método de prevención de adherencia utilizando el mismo. Específicamente, se proporciona un agente de prevención de la adhesión, que incluye al menos un tipo de nanomaterial anionizado seleccionado del grupo que consiste en: nanocelulosa anionizada; y nanoquitina anionizada, y un método de prevención de la adhesión que utiliza el agente de prevención de la adhesión.
ARP210101482A 2020-06-01 2021-06-01 Agente preventivo de adhesión y método preventivo de adhesión usando el mismo AR122491A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2020095280 2020-06-01

Publications (1)

Publication Number Publication Date
AR122491A1 true AR122491A1 (es) 2022-09-14

Family

ID=78831085

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210101482A AR122491A1 (es) 2020-06-01 2021-06-01 Agente preventivo de adhesión y método preventivo de adhesión usando el mismo

Country Status (13)

Country Link
US (1) US20230226098A1 (es)
EP (1) EP4159251A4 (es)
JP (2) JP7321610B2 (es)
KR (1) KR20230018490A (es)
CN (1) CN115884800A (es)
AR (1) AR122491A1 (es)
AU (1) AU2021284433A1 (es)
BR (1) BR112022022193A2 (es)
CA (1) CA3189526A1 (es)
MX (1) MX2022015193A (es)
TW (1) TW202210113A (es)
WO (1) WO2021246388A1 (es)
ZA (1) ZA202211627B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022132201A (ja) * 2021-02-26 2022-09-07 国立大学法人信州大学 表面修飾多糖類ナノ材料、その分散液及び機能性物品
CN114904053A (zh) * 2022-05-31 2022-08-16 重庆大学 一种基于纤维素纳米晶的抗炎防组织粘连生物涂层及其制备方法和应用
DE102023116601A1 (de) 2022-06-29 2024-01-04 Semiconductor Energy Laboratory Co., Ltd. Licht emittierende Vorrichtung

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610669B1 (en) * 1987-09-18 2003-08-26 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
IL96101A0 (en) * 1989-10-31 1991-07-18 Pfizer Hospital Prod Use of derivatives of chitin soluble in aqueous solutions for preventing adhesions
JP3545790B2 (ja) 1993-09-30 2004-07-21 味の素ファルマ株式会社 腹腔内の癒着防止剤
WO2005000374A1 (ja) 2003-06-30 2005-01-06 Denki Kagaku Kogyo Kabushiki Kaisha 脊椎・脊髄手術用癒着防止材
JP4998981B2 (ja) 2006-06-20 2012-08-15 国立大学法人 東京大学 微細セルロース繊維
JP5001246B2 (ja) 2008-09-26 2012-08-15 古河電池株式会社 蓄電池用モノブロック電槽
CA2794852A1 (en) * 2010-03-31 2011-10-06 Hogy Medical Co., Ltd. Adhesion-preventing material
CA2849750C (en) * 2011-09-30 2018-04-03 Nippon Paper Industries Co., Ltd. Method for producing cellulose nanofibers
US20150027648A1 (en) * 2012-03-14 2015-01-29 Nippon Paper Industries Co., Ltd., Method for producing anion-modified cellulose nanofiber dispersion
JP5921960B2 (ja) 2012-06-04 2016-05-24 第一工業製薬株式会社 無機微粒子含有組成物およびそれを用いた被膜
CA2912520C (en) 2013-05-16 2021-12-14 Oji Holdings Corporation Phosphoric acid-esterified fine cellulose fiber and method for producing the same
JP2015099083A (ja) 2013-11-19 2015-05-28 三菱重工業株式会社 酸露点腐食評価装置及び酸露点腐食評価方法
TW201538163A (zh) 2013-12-25 2015-10-16 Nissan Chemical Ind Ltd 血清及使血液固化之水分散液
JP2017155024A (ja) 2016-03-04 2017-09-07 株式会社ユーグレナ 細胞増殖促進剤
EP3489230B1 (en) 2016-07-21 2021-12-08 Nanjing Sanhome Pharmaceutical Co., Ltd. Chemical compound of isocitrate dehydrogenase inhibitor, and application thereof
US11535682B2 (en) 2017-01-16 2022-12-27 Yokogawa Electric Corporation Sulfate ester modified cellulose nanofibers and method for producing cellulose nanofibers
JP6958799B2 (ja) * 2017-05-25 2021-11-02 日本製紙株式会社 ハイドロゲル
US11713360B2 (en) 2017-06-16 2023-08-01 Toagosei Co., Ltd. Method for producing cellulose nanofibers
KR102031178B1 (ko) * 2017-07-14 2019-10-11 순천향대학교 산학협력단 주입형 온도감응성 목재 기반 산화 나노 셀룰로오스를 포함한 유착 방지제
EP3533458B1 (en) * 2018-03-02 2023-05-03 UPM-Kymmene Corporation A medical product comprising a bioactive molecule immobilized to nanofibrillar cellulose, and a method for preparing thereof
CN109966540B (zh) * 2019-04-04 2020-06-23 武汉大学 一种纳米甲壳素复合海藻酸钙医用敷料的制备方法及应用

Also Published As

Publication number Publication date
JP2023096193A (ja) 2023-07-06
BR112022022193A2 (pt) 2022-12-13
CN115884800A (zh) 2023-03-31
EP4159251A1 (en) 2023-04-05
US20230226098A1 (en) 2023-07-20
ZA202211627B (en) 2024-02-28
AU2021284433A1 (en) 2022-12-01
CA3189526A1 (en) 2021-12-09
TW202210113A (zh) 2022-03-16
WO2021246388A1 (ja) 2021-12-09
JPWO2021246388A1 (es) 2021-12-09
KR20230018490A (ko) 2023-02-07
MX2022015193A (es) 2023-01-04
JP7321610B2 (ja) 2023-08-07
EP4159251A4 (en) 2024-06-19

Similar Documents

Publication Publication Date Title
AR122491A1 (es) Agente preventivo de adhesión y método preventivo de adhesión usando el mismo
CL2023003068A1 (es) Compuestos, composiciones y métodos para el tratamiento de trastornos
UY38476A (es) Inhibidores de arg1 y/o arg2
CL2021002669A1 (es) (divisional de solicitud 3443-2018) tratamientos de cancer.
AR062212A1 (es) Composicion y metodo en relacion con la prevencion y la solucion del dano del gel surfactante
AR067563A1 (es) Polimeros funcionalizados, articulos preparaddos de los mismos, y sus metodos de eleboracion
CY1118655T1 (el) Χρηση 2,4-πυριμιδινοδιαμινων για τη θεραπεια της αθηροσκληρωσης
MX2023013173A (es) Degradadores de cinasa 2 dependiente de ciclina (cdk2) y sus usos.
AR032663A1 (es) Composicion de revestimiento mejorada
CO2021002691A2 (es) Composiciones y métodos para editar el gen hidroxiácido oxidasa 1 (hao1) para tratar la hiperoxaluria primaria tipo 1 (ph1)
BR112018071602A2 (pt) compostos de imidazopiridina substituídos como inibidores da indolamina 2,3-dioxigenase e/ou triptofano-2,3-dioxigenase
BR112018000701A2 (pt) composição de limpeza não corrosiva, altamente alcalina
MX2022008404A (es) Composiciones formadoras de pelicula para aplicar en plantas.
CO2022000481A2 (es) Inhibidores de enzimas
BR112023023578A2 (pt) Composto, composição farmacêutica compreendendo o composto e método de tratamento de uma leucemia aguda
BR112022008504A2 (pt) Composição de sabão
CL2025000822A1 (es) Inhibidores de pcsk9 y métodos de uso de los mismos.
WO2018144460A8 (en) Topcoat for permanent lip make up
MX2022005617A (es) Composicion adhesiva termofusible de polibuteno-1 catalizado por metaloceno y articulos que la incluye.
MX2019003987A (es) Estructuras fibrosas que comprenden compuestos de agave volatiles.
CO2025018165A2 (es) Agonistas de trem2
CO2024001405A2 (es) Composiciones y métodos para el tratamiento de cáncer
MX2025006791A (es) Agente de iarn con nucleótidos modificados
AR129796A1 (es) Composiciones de tirzepatida y uso
MX2021015970A (es) Terapia de combinacion con bloqueo de semaforina-4d (sema4d) y terapia de dc1.

Legal Events

Date Code Title Description
FG Grant, registration